Prediabetes — a condition that if left unchecked often leads to type 2 diabetes — is so common that U.S. public health officials often attempt to boost awareness about this relatively silent epidemic. The COVID-19 pandemic has spurred a new warning about prediabetes because the condition — along with fully diagnosed diabetes — puts individuals at higher risk for severe illness from COVID-19.
In the U.S., some 88 million Americans — more than 1 in 3 — are living with prediabetes, and more than 80 percent don’t even know they have it. Prediabetes can increase a person’s risk of developing type 2 diabetes, heart disease, and stroke. It often has no symptoms and goes undetected because those with the condition often don’t see a doctor for regular check-ups that can detect prediabetes in a basic blood work up.
The Goodbody Health Group Inc. is listed on the Canadian Securities Exchange (CSE), the Aquis Stock Exchange – Growth Market (AQSE) Apex segment, OTC and Frankfurt Stock Exchange (FSE), providing current and prospective shareholders with multiple platforms in which to buy and sell Goodbody Health Group Inc. stock under the EPIC codes: CSE: GDBY / AQSE: GDBY / FRA: 484 / OTC: GDBYF).